156 related articles for article (PubMed ID: 20638458)
1. A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactor.
Lohr V; Genzel Y; Behrendt I; Scharfenberg K; Reichl U
Vaccine; 2010 Aug; 28(38):6256-64. PubMed ID: 20638458
[TBL] [Abstract][Full Text] [Related]
2. Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media.
Genzel Y; Olmer RM; Schäfer B; Reichl U
Vaccine; 2006 Aug; 24(35-36):6074-87. PubMed ID: 16781022
[TBL] [Abstract][Full Text] [Related]
3. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.
Genzel Y; Fischer M; Reichl U
Vaccine; 2006 Apr; 24(16):3261-72. PubMed ID: 16472544
[TBL] [Abstract][Full Text] [Related]
4. Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process.
George M; Farooq M; Dang T; Cortes B; Liu J; Maranga L
Biotechnol Bioeng; 2010 Aug; 106(6):906-17. PubMed ID: 20589670
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a mink enteritis vaccine production process in stirred-tank reactor and Wave Bioreactor microcarrier culture in 1-10 L scale.
Hundt B; Best C; Schlawin N; Kassner H; Genzel Y; Reichl U
Vaccine; 2007 May; 25(20):3987-95. PubMed ID: 17391818
[TBL] [Abstract][Full Text] [Related]
6. Production of high-titer human influenza A virus with adherent and suspension MDCK cells cultured in a single-use hollow fiber bioreactor.
Tapia F; Vogel T; Genzel Y; Behrendt I; Hirschel M; Gangemi JD; Reichl U
Vaccine; 2014 Feb; 32(8):1003-11. PubMed ID: 24269322
[TBL] [Abstract][Full Text] [Related]
7. Comparison of influenza virus yields and apoptosis-induction in an adherent and a suspension MDCK cell line.
Peschel B; Frentzel S; Laske T; Genzel Y; Reichl U
Vaccine; 2013 Nov; 31(48):5693-9. PubMed ID: 24113260
[TBL] [Abstract][Full Text] [Related]
8. Comparison of a production process in a membrane-aerated stirred tank and up to 1000-L airlift bioreactors using BHK-21 cells and chemically defined protein-free medium.
Hesse F; Ebel M; Konisch N; Sterlinski R; Kessler W; Wagner R
Biotechnol Prog; 2003; 19(3):833-43. PubMed ID: 12790647
[TBL] [Abstract][Full Text] [Related]
9. Production of canine adenovirus type 2 in serum-free suspension cultures of MDCK cells.
Castro R; Fernandes P; Laske T; Sousa MF; Genzel Y; Scharfenberg K; Alves PM; Coroadinha AS
Appl Microbiol Biotechnol; 2015 Sep; 99(17):7059-68. PubMed ID: 25994255
[TBL] [Abstract][Full Text] [Related]
10. New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation.
Lohr V; Rath A; Genzel Y; Jordan I; Sandig V; Reichl U
Vaccine; 2009 Aug; 27(36):4975-82. PubMed ID: 19531390
[TBL] [Abstract][Full Text] [Related]
11. Mathematical model of influenza A virus production in large-scale microcarrier culture.
Möhler L; Flockerzi D; Sann H; Reichl U
Biotechnol Bioeng; 2005 Apr; 90(1):46-58. PubMed ID: 15736163
[TBL] [Abstract][Full Text] [Related]
12. CAP, a new human suspension cell line for influenza virus production.
Genzel Y; Behrendt I; Rödig J; Rapp E; Kueppers C; Kochanek S; Schiedner G; Reichl U
Appl Microbiol Biotechnol; 2013 Jan; 97(1):111-22. PubMed ID: 22821436
[TBL] [Abstract][Full Text] [Related]
13. Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing.
Le Ru A; Jacob D; Transfiguracion J; Ansorge S; Henry O; Kamen AA
Vaccine; 2010 May; 28(21):3661-71. PubMed ID: 20347632
[TBL] [Abstract][Full Text] [Related]
14. Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines.
Hu AY; Weng TC; Tseng YF; Chen YS; Wu CH; Hsiao S; Chou AH; Chao HJ; Gu A; Wu SC; Chong P; Lee MS
Vaccine; 2008 Oct; 26(45):5736-40. PubMed ID: 18761387
[TBL] [Abstract][Full Text] [Related]
15. Suitability of MDCK cells grown in a serum-free medium for influenza virus production.
Kessler N; Thomas-Roche G; Gérentes L; Aymard M
Dev Biol Stand; 1999; 98():13-21; discussion 73-4. PubMed ID: 10494956
[TBL] [Abstract][Full Text] [Related]
16. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
Rourou S; van der Ark A; van der Velden T; Kallel H
Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
[TBL] [Abstract][Full Text] [Related]
17. MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation.
Genzel Y; Dietzsch C; Rapp E; Schwarzer J; Reichl U
Appl Microbiol Biotechnol; 2010 Sep; 88(2):461-75. PubMed ID: 20617311
[TBL] [Abstract][Full Text] [Related]
18. Use of MDCK cells for production of live attenuated influenza vaccine.
Liu J; Shi X; Schwartz R; Kemble G
Vaccine; 2009 Oct; 27(46):6460-3. PubMed ID: 19559113
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture.
Genzel Y; Behrendt I; König S; Sann H; Reichl U
Vaccine; 2004 Jun; 22(17-18):2202-8. PubMed ID: 15149778
[TBL] [Abstract][Full Text] [Related]
20. Production of influenza virus in serum-free mammalian cell cultures.
Merten OW; Manuguerra JC; Hannoun C; van der Werf S
Dev Biol Stand; 1999; 98():23-37; discussion 73-4. PubMed ID: 10494957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
